Insect Gene Expression via Alternative Splicing Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene expression systems lack efficient mechanisms for regulating alternative splicing, particularly in a sex-specific, stage-specific, germline-specific, or tissue-specific manner, which is crucial for various developmental processes and therapeutic applications.
Innovation Solution
A polynucleotide expression system comprising a heterologous polynucleotide sequence encoded between a start and stop codon, operably linked with a promoter and splice control sequences that mediate splicing to produce alternative mRNA products, allowing for sex-specific, stage-specific, germline-specific, or tissue-specific expression of functional proteins or interference RNA.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional gene expression systems are used, then protein expression can be achieved, but precise control over sex-specific, stage-specific, germline-specific, or tissue-specific expression is lacking
Solution Approach 1:
The patent divides the expression system into modular components: promoter regions, splice control sequences with specific binding sites for sex-determination proteins (Sxl, Tra, dsx), coding sequences, and regulatory elements. Each module can be independently selected and combined to achieve desired expression patterns in different tissues, stages, or sexes, providing precise control without excessive complexity.
Solution Approach 2:
The patent introduces tissue-specific and sex-specific regulatory elements at specific locations within the gene structure. For example, sex-specific splice control sequences are placed in introns or 5' UTR regions to control alternative splicing in a sex-specific manner, while tissue-specific promoters are positioned at the 5' end to drive expression in particular tissues. This localized placement of regulatory functions enables precise spatial and temporal control of protein expression.
2Reliability
If the Sterile Insect Technique is used for population control, then insect populations can be reduced, but the method has limitations including cost, safety concerns, and reduced competitiveness of irradiated organisms
Solution Approach 1:
The patent uses sex-determination proteins (Sxl, Tra, dsx) and their binding sites as intermediaries to control gene expression in a sex-specific manner. The splice control sequences act as mediators that recruit these proteins to regulate alternative splicing, enabling selective expression of lethal genes in one sex while leaving the other sex unaffected. This molecular mediation provides a more precise and safer alternative to irradiation-based methods.
Solution Approach 2:
The patent changes the regulatory parameters of gene expression by introducing sex-specific splice control sequences that alter splicing patterns based on the sex of the organism. By modifying the splicing regulation parameters through specific binding sites for Sxl, Tra, and dsx proteins, the system achieves sex-specific expression of transgenes, enabling targeted population control without the adverse effects of irradiation.
3Adaptability or versatility
If alternative splicing is used to regulate gene expression, then multiple mRNA products can be generated from a single gene, but efficient mechanisms for sex-specific, stage-specific, germline-specific, or tissue-specific control are lacking
Solution Approach 1:
The patent employs universal splice control sequences that can be applied to multiple genes and organisms to achieve sex-specific, stage-specific, and tissue-specific expression. The same basic architecture of splice control sequences with binding sites for Sxl, Tra, and dsx proteins can regulate alternative splicing in different contexts (sex determination, developmental stages, tissue types), providing a versatile and relatively simple mechanism for generating multiple mRNA products from single genes across diverse applications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise control over protein expression, achieving therapeutic effects or marking proteins in a targeted manner, such as inducing apoptosis or acting as a marker, while avoiding the limitations of existing techniques like the Sterile Insect Technique.
Implementation Method 1
Alternative splicing involves the removal of one or more introns and ligation of the flanking exons. This reaction is catalyzed by the spliceosome, a macromolecular machine composed of five RNAs and hundreds of proteins
Implementation Method 2
at least one splice control sequence which, in cooperation with a spliceosome, is capable of (i) mediating splicing of an RNA transcript of the coding sequence to yield a first spliced messenger RNA (mRNA) product, and (ii) mediating at least one alternative splicing of said RNA transcript to yield an alternative spliced mRNA product
Data Source
AI summary
A polynucleotide expression system is provided that is capable of alternative splicing of RNA transcripts of a polynucleotide sequence to be expressed in an organism.